Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.



Elizabeth Williams
CEO and co-founder, Hemideina
Talk to the deal team
Related deals
Danish leader in access control systems has been sold to Vækst-Invest
Unitek, a leading provider of innovative access control systems in Denmark, has been acquired by the Danish private equity firm Vækst-Invest to drive its growth and expansion.
Learn moreGenerali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.
Learn moreSTM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn more